Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma. (Q51401479)
Jump to navigation
Jump to search
scientific article published on 15 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma. |
scientific article published on 15 March 2012 |
Statements
1 reference
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma. (English)
1 reference
1 reference
1 reference
S Vincent Rajkumar
1 reference
Paul G Richardson
1 reference
Shaji Kumar
1 reference
Natalie Callander
1 reference
Stephen J Noga
1 reference
A Keith Stewart
1 reference
Francesco Turturro
1 reference
Robert Rifkin
1 reference
Jeffrey Wolf
1 reference
Jose Estevam
1 reference
George Mulligan
1 reference
Hongliang Shi
1 reference
Iain J Webb
1 reference
15 March 2012
1 reference
1 reference
119
1 reference
4375-4382
1 reference
19
1 reference
Identifiers
1 reference